| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.054 | 0.3 |
| mRNA | tretinoin:carboplatin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | AP-24534 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.3 |
| mRNA | TAE684 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |